RSS Atom • ISSN 1472-4683 • Subscribe • About
2002
- Majority of HIV patients in San Francisco study use alternative medicines Other news - 13 October 2002
- Opportunistic infections and coinfections: focus on fungi and hepatitis On the web - 13 October 2002
- XI International HIV Drug Resistance Workshop: basic principles and clinical implications; Seville, Spain July 2-5, 2002 On the web - 13 October 2002
- XI International HIV Drug Resistance Workshop, Seville, 2-5 July, 2002 Conference reports - Conference index - Intl Drug Resistance Workshop 11 Sitges 2002 - 11 September 2002
- Short resistance reports from Seville Conference reports - Resistance - Intl Drug Resistance Workshop 11 Sitges 2002 - 11 September 2002
- Review of phenotypic resistance testing data presented at the XI International HIV Drug Resistance Workshop Conference reports - Resistance - Intl Drug Resistance Workshop 11 Sitges 2002 - 11 September 2002
- Lives were lost as experts argued the merits of care versus prevention, says Stefano Vella Conference reports - Treatment access - 11 September 2002
- Peter Piot sets out the global political agenda in the fight against HIV/AIDS Conference reports - Treatment access - 11 September 2002
- Governments must act to cut drug prices, says Kenya's health minister Conference reports - Treatment access - 11 September 2002
- Coalitions of local NGOs can effectively demand access to medicines, reports MSF Conference reports - Treatment access - 11 September 2002
- Involvement of PLWHA is key to improving access to treatments Conference reports - Treatment access - 11 September 2002
- Prolonged CNS side-effects of efavirenz can be severe and lead to treatment discontinuation Conference reports - Side effects - 11 September 2002
- HIV-associated malignancies in the HAART era: flickers of hope and understanding Cancer and HIV - Conference reports - 11 September 2002
- Antiretroviral use in pregnancy and the risk of an adverse outcome PMTCT and maternal health - 11 September 2002
- Peripheral neuropathy: new data on risk factors, incidence and association with viral load Side effects - 11 September 2002
- Gene discovery offers fresh perspective on HIV/AIDS therapies Basic science and immunology - 11 September 2002
- Growth hormone effective in increasing thymic activity Basic science and immunology - 11 September 2002
- HIV long term nonprogressors have increased immune responsiveness to other viral pathogens Basic science and immunology - 11 September 2002
- Red blood cells new sensitive markers for HIV disease progression? Basic science and immunology - 11 September 2002
- Increased risk of heart abnormalities in children born to mothers with HIV-1 Paediatric care - 11 September 2002
- Paclitaxel effective for advanced AIDS-related Kaposi Sarcoma Cancer and HIV - Opportunistic infections and complications - 11 September 2002
- Study finds sexual dysfunction common in HIV-positive men receiving HAART but unrelated to protease inhibitors Other news - 11 September 2002
- ViroLogic announces launch of 'viral fitness' assay for HIV infection Other news - 11 September 2002
- Mycobacterium avium complex and atypical mycobacterial infections in the setting of HIV infection On the web - 11 September 2002
- Anaemia, neutropenia, and thrombocytopenia: pathogenesis and evolving treatment options in HIV-positive patients On the web - 11 September 2002
- 'Natural' resistance to HIV: is the evidence good enough to design an effective vaccine? On the web - 11 September 2002
- High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia On the web - 11 September 2002
- Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1 Treatment access - 11 July 2002
- US foundation bars GlaxoSmithKline representatives over AIDS drug pricing Treatment access - 11 July 2002
- Updated guidelines for using antiretroviral agents among HIV-positive adults and adolescents: recommendations of the Panel on Clinical Practices for Treatment of HIV Guidelines - 11 July 2002
- In switch study, women twice as likely as men to discontinue HAART due to toxicities Side effects - Women's health - 11 July 2002